These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 29298863

  • 1. Dual regulation of HMGB1 by combined JNK1/2-ATF2 axis with miR-200 family in nonalcoholic steatohepatitis in mice.
    Chen X, Ling Y, Wei Y, Tang J, Ren Y, Zhang B, Jiang F, Li H, Wang R, Wen W, Lv G, Wu M, Chen L, Li L, Wang H.
    FASEB J; 2018 May; 32(5):2722-2734. PubMed ID: 29298863
    [Abstract] [Full Text] [Related]

  • 2. Hepatocyte free cholesterol lipotoxicity results from JNK1-mediated mitochondrial injury and is HMGB1 and TLR4-dependent.
    Gan LT, Van Rooyen DM, Koina ME, McCuskey RS, Teoh NC, Farrell GC.
    J Hepatol; 2014 Dec; 61(6):1376-84. PubMed ID: 25064435
    [Abstract] [Full Text] [Related]

  • 3. FBXW7 suppresses HMGB1-mediated innate immune signaling to attenuate hepatic inflammation and insulin resistance in a mouse model of nonalcoholic fatty liver disease.
    Zhang C, Chen F, Feng L, Shan Q, Zheng GH, Wang YJ, Lu J, Fan SH, Sun CH, Wu DM, Li MQ, Hu B, Wang QQ, Zhang ZF, Zheng YL.
    Mol Med; 2019 Jun 18; 25(1):29. PubMed ID: 31215394
    [Abstract] [Full Text] [Related]

  • 4. Palmitic acid induces autophagy in hepatocytes via JNK2 activation.
    Tu QQ, Zheng RY, Li J, Hu L, Chang YX, Li L, Li MH, Wang RY, Huang DD, Wu MC, Hu HP, Chen L, Wang HY.
    Acta Pharmacol Sin; 2014 Apr 18; 35(4):504-12. PubMed ID: 24608675
    [Abstract] [Full Text] [Related]

  • 5. Downregulation of microRNA-451 in non-alcoholic steatohepatitis inhibits fatty acid-induced proinflammatory cytokine production through the AMPK/AKT pathway.
    Hur W, Lee JH, Kim SW, Kim JH, Bae SH, Kim M, Hwang D, Kim YS, Park T, Um SJ, Song BJ, Yoon SK.
    Int J Biochem Cell Biol; 2015 Jul 18; 64():265-76. PubMed ID: 25957914
    [Abstract] [Full Text] [Related]

  • 6. c-Jun N-terminal kinase-1 from hematopoietic cells mediates progression from hepatic steatosis to steatohepatitis and fibrosis in mice.
    Kodama Y, Kisseleva T, Iwaisako K, Miura K, Taura K, De Minicis S, Osterreicher CH, Schnabl B, Seki E, Brenner DA.
    Gastroenterology; 2009 Oct 18; 137(4):1467-1477.e5. PubMed ID: 19549522
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA-29a Suppresses CD36 to Ameliorate High Fat Diet-Induced Steatohepatitis and Liver Fibrosis in Mice.
    Lin HY, Wang FS, Yang YL, Huang YH.
    Cells; 2019 Oct 22; 8(10):. PubMed ID: 31652636
    [Abstract] [Full Text] [Related]

  • 8. MiR-150 deficiency ameliorated hepatosteatosis and insulin resistance in nonalcoholic fatty liver disease via targeting CASP8 and FADD-like apoptosis regulator.
    Zhuge B, Li G.
    Biochem Biophys Res Commun; 2017 Dec 16; 494(3-4):687-692. PubMed ID: 29107687
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Differential effects of JNK1 and JNK2 inhibition on murine steatohepatitis and insulin resistance.
    Singh R, Wang Y, Xiang Y, Tanaka KE, Gaarde WA, Czaja MJ.
    Hepatology; 2009 Jan 16; 49(1):87-96. PubMed ID: 19053047
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. JNK1 but not JNK2 promotes the development of steatohepatitis in mice.
    Schattenberg JM, Singh R, Wang Y, Lefkowitch JH, Rigoli RM, Scherer PE, Czaja MJ.
    Hepatology; 2006 Jan 16; 43(1):163-72. PubMed ID: 16374858
    [Abstract] [Full Text] [Related]

  • 13. Intracellular and extracellular miRNome deregulation in cellular models of NAFLD or NASH: Clinical implications.
    Di Mauro S, Ragusa M, Urbano F, Filippello A, Di Pino A, Scamporrino A, Pulvirenti A, Ferro A, Rabuazzo AM, Purrello M, Purrello F, Piro S.
    Nutr Metab Cardiovasc Dis; 2016 Dec 16; 26(12):1129-1139. PubMed ID: 27756518
    [Abstract] [Full Text] [Related]

  • 14. A negative feedback loop between microRNA-378 and Nrf1 promotes the development of hepatosteatosis in mice treated with a high fat diet.
    Zhang T, Zhao X, Steer CJ, Yan G, Song G.
    Metabolism; 2018 Aug 16; 85():183-191. PubMed ID: 29625129
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Nuclear factor high-mobility group box1 mediating the activation of Toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice.
    Li L, Chen L, Hu L, Liu Y, Sun HY, Tang J, Hou YJ, Chang YX, Tu QQ, Feng GS, Shen F, Wu MC, Wang HY.
    Hepatology; 2011 Nov 16; 54(5):1620-30. PubMed ID: 21809356
    [Abstract] [Full Text] [Related]

  • 17. Interleukin-17A exacerbates high-fat diet-induced hepatic steatosis by inhibiting fatty acid β-oxidation.
    Shen T, Chen X, Li Y, Tang X, Jiang X, Yu C, Zheng Y, Guo H, Ling W.
    Biochim Biophys Acta Mol Basis Dis; 2017 Jun 16; 1863(6):1510-1518. PubMed ID: 28153707
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. MiR-146b attenuates high-fat diet-induced non-alcoholic steatohepatitis in mice.
    Jiang W, Liu J, Dai Y, Zhou N, Ji C, Li X.
    J Gastroenterol Hepatol; 2015 May 16; 30(5):933-43. PubMed ID: 25559563
    [Abstract] [Full Text] [Related]

  • 20. Down-regulation of miR-144 elicits proinflammatory cytokine production by targeting toll-like receptor 2 in nonalcoholic steatohepatitis of high-fat-diet-induced metabolic syndrome E3 rats.
    Li D, Wang X, Lan X, Li Y, Liu L, Yi J, Li J, Sun Q, Wang Y, Li H, Zhong N, Holmdahl R, Lu S.
    Mol Cell Endocrinol; 2015 Feb 15; 402():1-12. PubMed ID: 25534427
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.